![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SZRD1 |
Gene summary for SZRD1 |
![]() |
Gene information | Species | Human | Gene symbol | SZRD1 | Gene ID | 26099 |
Gene name | SUZ RNA binding domain containing 1 | |
Gene Alias | C1orf144 | |
Cytomap | 1p36.13 | |
Gene Type | protein-coding | GO ID | NA | UniProtAcc | Q7Z422 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
26099 | SZRD1 | LZE2T | Human | Esophagus | ESCC | 1.98e-04 | 3.23e-01 | 0.082 |
26099 | SZRD1 | LZE4T | Human | Esophagus | ESCC | 3.89e-05 | 1.05e-01 | 0.0811 |
26099 | SZRD1 | LZE7T | Human | Esophagus | ESCC | 1.13e-04 | 4.59e-01 | 0.0667 |
26099 | SZRD1 | LZE8T | Human | Esophagus | ESCC | 3.30e-10 | 3.79e-01 | 0.067 |
26099 | SZRD1 | LZE20T | Human | Esophagus | ESCC | 6.17e-08 | 3.62e-01 | 0.0662 |
26099 | SZRD1 | LZE22T | Human | Esophagus | ESCC | 1.65e-05 | 3.91e-01 | 0.068 |
26099 | SZRD1 | LZE24T | Human | Esophagus | ESCC | 5.80e-21 | 5.21e-01 | 0.0596 |
26099 | SZRD1 | LZE6T | Human | Esophagus | ESCC | 2.15e-04 | 4.46e-01 | 0.0845 |
26099 | SZRD1 | P1T-E | Human | Esophagus | ESCC | 6.23e-07 | 5.62e-01 | 0.0875 |
26099 | SZRD1 | P2T-E | Human | Esophagus | ESCC | 9.64e-44 | 9.38e-01 | 0.1177 |
26099 | SZRD1 | P4T-E | Human | Esophagus | ESCC | 1.49e-29 | 6.51e-01 | 0.1323 |
26099 | SZRD1 | P5T-E | Human | Esophagus | ESCC | 1.75e-19 | 3.25e-01 | 0.1327 |
26099 | SZRD1 | P8T-E | Human | Esophagus | ESCC | 3.57e-31 | 5.78e-01 | 0.0889 |
26099 | SZRD1 | P9T-E | Human | Esophagus | ESCC | 3.36e-25 | 3.87e-01 | 0.1131 |
26099 | SZRD1 | P10T-E | Human | Esophagus | ESCC | 1.18e-37 | 7.31e-01 | 0.116 |
26099 | SZRD1 | P11T-E | Human | Esophagus | ESCC | 3.21e-15 | 7.69e-01 | 0.1426 |
26099 | SZRD1 | P12T-E | Human | Esophagus | ESCC | 5.01e-21 | 4.87e-01 | 0.1122 |
26099 | SZRD1 | P15T-E | Human | Esophagus | ESCC | 7.94e-31 | 7.83e-01 | 0.1149 |
26099 | SZRD1 | P16T-E | Human | Esophagus | ESCC | 3.07e-24 | 4.20e-01 | 0.1153 |
26099 | SZRD1 | P17T-E | Human | Esophagus | ESCC | 1.40e-16 | 7.23e-01 | 0.1278 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Oral cavity | OSCC | ![]() |
Oral cavity | LP | ![]() |
Oral cavity | EOLP | ![]() |
Oral cavity | NEOLP | ![]() |
Esophagus | HGIN | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SZRD1 | SNV | Missense_Mutation | c.200N>T | p.Thr67Ile | p.T67I | Q7Z422 | protein_coding | deleterious(0) | benign(0.179) | TCGA-A8-A090-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SZRD1 | SNV | Missense_Mutation | novel | c.422N>A | p.Gly141Asp | p.G141D | Q7Z422 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-BH-A0E2-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
SZRD1 | SNV | Missense_Mutation | c.192N>C | p.Lys64Asn | p.K64N | Q7Z422 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-E2-A152-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Targeted Molecular therapy | trastuzumab | PD | |
SZRD1 | insertion | Frame_Shift_Ins | novel | c.163_164insCCTTCTCAGCCTCTTTCTTCTCTCTGCTTTTCTCTAAAAT | p.Gly55AlafsTer93 | p.G55Afs*93 | Q7Z422 | protein_coding | TCGA-A8-A06P-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unspecific | SD | |||
SZRD1 | SNV | Missense_Mutation | novel | c.325N>A | p.Glu109Lys | p.E109K | Q7Z422 | protein_coding | deleterious(0) | benign(0.153) | TCGA-VS-A94X-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
SZRD1 | insertion | Frame_Shift_Ins | novel | c.60_61insA | p.Arg21LysfsTer31 | p.R21Kfs*31 | Q7Z422 | protein_coding | TCGA-VS-A8EK-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | PD | ||
SZRD1 | SNV | Missense_Mutation | rs374656978 | c.452N>A | p.Arg151His | p.R151H | Q7Z422 | protein_coding | tolerated(0.35) | possibly_damaging(0.886) | TCGA-EI-6917-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5fluorouracil+oxaciplatina+l-folinian | SD |
SZRD1 | SNV | Missense_Mutation | novel | c.302N>A | p.Arg101Gln | p.R101Q | Q7Z422 | protein_coding | deleterious(0.05) | probably_damaging(0.988) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
SZRD1 | SNV | Missense_Mutation | rs374656978 | c.452G>A | p.Arg151His | p.R151H | Q7Z422 | protein_coding | tolerated(0.35) | possibly_damaging(0.886) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SZRD1 | SNV | Missense_Mutation | c.65N>A | p.Arg22Gln | p.R22Q | Q7Z422 | protein_coding | tolerated(0.12) | probably_damaging(0.953) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |